Learning Objectives

  1. Review results from the FLOW Randomized Clinical Trial: Impact of GLP-1 Receptor Agonist (GLP-1 RA) on Cardiovascular MACE in NIDDM Kidney Disease
  2. Meta-Analytic Impact of GLP-1 RA on Kidney and Cardiovascular MACE
  3. Assess Mechanisms by Which GLP-1 RA Reduce CV Risk in Diabetes

Faculty: Katherine R. Tuttle, MD, FASN, FACP, FNKF

Session date: 
12/18/2024 - 12:00pm to 1:00pm EST
Location: 
Boston Medical Center
72 E. Concord Street
Collamore 8
Boston, MA 02118
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 Participation

Please login or register to take this course.